H1 Results H1 Results show steady sales progress and excellent cash flow.I do like APH's no-nonsense accounts, no sneaky hidden things, allfacts honest & plain for all to see.I hold APH long term (dividends beat bank interest, and there isnear constant sensible growth. ws
Re: Diclectin It's interesting - the drug is already approved in Canada and the FDAC but the MHRA rejected it.I wouldn't say it's written off just yet, but I'd like to hear why it was rejected in the first place. Perhaps the MHRA want more data submitted to them as it is going to be used by pregnant females.
Re: Dropped again I will take a further look at OPG when there is substantial volume and it is above the moving averages.
Re: Dropped again Share Crazy - Have a look at OPG Power (OPG), should I prove to be correct in my views/comments there, then a substantial can't be toofar away there. But as always take care and DYOR.]As for APH, I reckon we'll see 55p+ there in the not too distant future,not a race horse, just a quiet docile work horse.IMHO,ws
Re: Dropped again You seem like an astute investor judging by your comments on iii. It seems like Iomart on the cusp of going down even though it should be going up! Patience of a saint required.
Re: Dropped again In the stocks & shares investment world, no one sails along without mistakes.I consider it a mistake to be selling APH. When the market takes a tumble (which could happen any day) then established healthcare stocks like APHare likely to suffer least. In my view, APH is a steady ship to sail on.INHO,ws
Re: Dropped again Why did Nigel Wray and Bank of Canada sell? The chart isn't shaping up very well, but there has been no volume yet.
Doubled Up Oh well in for a penny, in for .......Games
Re: Dropped again Games - The diclectiin issue is disappointing but by no means disastrous. The share price need not go down as much as it has,I reckon that we'll see a bottom at around 49p and then a gradual rise again to region 52+. After all, the company's profitsare rising nicely without diclectin and the Dividend is good and also rising nicely.IMHO,ws
Dropped again I have this on my screen down another 2.44% to 50Looks like the Diclectin failure is putting on the spotlight on the managements judgement here.Is there further to fall?If it drops below 50 it could keep going for a while possibly.Games -- only a small position in yhis so far.
Diclectin Looks like £1.5m has to be written off. Not exactly a total disaster against operating profit of £25m-£30m.IMO,ws
Today In recent days two big sellers have sold. Today's news it seems wasn't too detrimental according to the company. There wasn't volume to the sell off. If it moves below the 100 day moving average I will consider a short to hedge my long. What do you think?
Re: In Welcome on board. This should be a steady ship, movingquietly forward at steady pace. Good luck.ws
In 1st tranche todayGames
Re: Share dilution Winning -- I'll take a look and it certainly seems to have some good history, however, I'm not usually a big fan of consulting companies as they tend to be expensive people wise, high operationally, especially when business turns south.The only investment made since dropping AZN-GSK and Rathbones is OPG Power Ventures -- not a huge position and it's a strange choice for me, it being coal oreintated (moving into solar) but the fundamentals look good and it's incredibly undervalued if not a tad heavy ion debt.It's highlighted by the Slater Growth Fund. -- see OPG board.Games